Metabolic syndrome (MetS) includes visceral obesity, hyperglycemia, dyslipidemia, and
hypertension. The prevalence of MetS is 20-25%, which is an important risk factor for chronic …

The prevalence of kidney disease is increasing rapidly worldwide, reflecting rising rates of
obesity, diabetes, and associated metabolic syndrome (MetS). Chronic kidney disease and …

Background. Hashimoto's thyroiditis (HT) is an auto-immune condition characterized with
lymphocytic and fibroblastic infiltration of the thyroid gland. The rate of uric acid and HDL …

Objective This study assessed the efficacy of INV-202, a novel peripherally restricted
cannabinoid type-1 receptor (CB1R) inverse agonist, in a streptozotocin-induced type-1 …

Cannabinoid receptors typically include type 1 (CB1) and type 2 (CB2), and they have
attracted extensive attention in the central nervous system (CNS) and immune system. Due …

The prognosis of hypertension leads to organ damage by causing nephropathy, stroke,
retinopathy, and cardiomegaly. Retinopathy and blood pressure have been extensively …

ABSTRACT Diabetic Kidney Disease (DKD), a frequent consequence of diabetes, has
substantial implications for both morbidity and mortality rates, prompting the exploration of …

Prognosis of hypertension leads to organ damage by causing nephropathy, stroke,
retinopathy and cardiomegaly. Kidney, retinopathy and blood pressure (BP) have been …

Background Diabetic Kidney Disease (DKD) is a significant challenge in healthcare.
However, there are currently no reliable biomarkers for renal impairment diagnosis …

Metabolic syndrome (MetS) is a combination of metabolic disorders that can predispose
individuals to benign prostatic hyperplasia (BPH). The inhibition of the cannabinoid 1 (CB1) …